SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-11-018295
Filing Date
2011-04-01
Accepted
2011-04-01 18:37:00
Documents
2
Period of Report
2011-04-01

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 6027
2 EX-24.1 ex-24d1.htm EX-24.1 8011
  Complete submission text file 0001104659-11-018295.txt   16141
Mailing Address
Business Address 2 GREENVILLE CROSSING 4005 KENNETT PIKE STE 220 GREENVILLE DE 19807
QUAKER BIO VENTURES LP (Reporting) CIK: 0001170144 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35119 | Film No.: 11733027

Mailing Address
Business Address 435 DOVER PARK DRIVE BLDG 500 WAYNE PA 19087 2159886811
QUAKER BIOVENTURES CAPITAL LP (Reporting) CIK: 0001223034 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35119 | Film No.: 11733026

Mailing Address 4819 EMPEROR BOULEVARD, SUITE 400 DURHAM NC 27703
Business Address 4819 EMPEROR BOULEVARD, SUITE 400 DURHAM NC 27703 919 313-4760
TRANZYME INC (Issuer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O QUAKER BIOVENTURES CIRCA CENTRE, 2929 ARCH STREET PHILADELPHIA PA 19104
Business Address
Gavin Brenda D (Reporting) CIK: 0001488182 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35119 | Film No.: 11733028